3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Kidney Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Surveys and Questionnaires
22
Blood Specimen Collection
13
niraparib
8
Cytoreduction Surgical Procedures
8
Hyperthermic Intraperitoneal Chemotherapy
7
Interviews as Topic
6
Immunohistochemistry
6
olaparib
5
Psychiatric Rehabilitation
5
Polymerase Chain Reaction
5
Magnetic Resonance Spectroscopy
5
Data Collection
5
Carboplatin
5
Amplified Fragment Length Polymorphism Analysis
5
liposomal doxorubicin
4
Geriatric Assessment
4
Bevacizumab
4
1-dodecylpyridoxal
4
Ultrasonography
3
Trabectedin
3
Therapeutics
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Phlebotomy
3
Observation
3
Neoadjuvant Therapy
3
Microarray Analysis
3
Laparoscopy
3
Gene Expression Profiling
3
Flow Cytometry
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Ovarian Neoplasms
×
Blood Component Removal
×
Clear all
NCT04981119
2026-06-02
BASECAMP-1
A2 Biotherapeutics Inc.
Recruiting
200 enrolled